{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:27:22Z","timestamp":1773282442767,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["U51HA0252"],"award-info":[{"award-number":["U51HA0252"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["PS 001058"],"award-info":[{"award-number":["PS 001058"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0164030","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T17:59:58Z","timestamp":1476986398000},"page":"e0164030","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Long-Term Outcomes on Antiretroviral Therapy in a Large Scale-Up Program in Nigeria"],"prefix":"10.1371","volume":"11","author":[{"given":"Seema T.","family":"Meloni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyin","family":"Jolayemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolanle","family":"Banigbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prosper I.","family":"Okonkwo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis J.","family":"Kanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. The Gap Report. 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/sites\/default\/files\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2014\/UNAIDS_Gap_report_en.pdf\" xlink:type=\"simple\">http:\/\/www.unaids.org\/sites\/default\/files\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2014\/UNAIDS_Gap_report_en.pdf<\/ext-link>."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1371\/journal.pone.0000089","article-title":"Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort","volume":"1","author":"F Gutierrez","year":"2006","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/QAI.0000000000000268","article-title":"Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs","volume":"67","author":"A Grimsrud","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1758-2652-12-38","article-title":"Long term outcomes of antiretroviral therapy in a large HIV\/AIDS care clinic in urban South Africa: a prospective cohort study","volume":"12","author":"IM Sanne","year":"2009","journal-title":"J Int AIDS Soc"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/QAI.0000000000000753","article-title":"Brief Report: Long-term outcomes and their determinants in patients on antiretroviral treatment in Ethiopia, 2005\/6-2011\/12: A Retrospective Cohort Study","volume":"70","author":"Y Assefa","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/QAI.0000000000000604","article-title":"Gender differences in adherence and response to antiretroviral treatment in the Stratall Trial in rural district hospitals in Cameroon","volume":"69","author":"C Boulle","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e0142722","DOI":"10.1371\/journal.pone.0142722","article-title":"Outcomes in a cohort of patients started on antiretroviral treatment and followed up for a decade in an urban clinic in Uganda","volume":"10","author":"B Castelnuovo","year":"2015","journal-title":"PLoS One"},{"key":"ref8","article-title":"Continuous retention and viral suppression provide further insights into the HIV care continuum compared to the cross-sectional HIV care cascade","author":"J Colasanti","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e007508","DOI":"10.1136\/bmjopen-2014-007508","article-title":"Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003\u20132014","volume":"5","author":"P Huang","year":"2015","journal-title":"BMJ Open"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/apc.2014.0232","article-title":"Impact of gender on long-term treatment outcomes of Highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database","volume":"29","author":"MP Lee","year":"2015","journal-title":"AIDS Patient Care STDS"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/QAD.0000000000000790","article-title":"Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes","volume":"29","author":"VD Lima","year":"2015","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/QAI.0000000000000652","article-title":"Disparities in initiation of combination antiretroviral treatment and in virologic suppression among patients in the HIV Outpatient Study, 2000\u20132013","volume":"70","author":"RM Novak","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref13","unstructured":"Federal Republic of Nigeria National Agency for the Control of AIDS. Global AIDS response: Country progress report, Nigeria. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/sites\/default\/files\/country\/documents\/NGA_narrative_report_2015.pdf\" xlink:type=\"simple\">http:\/\/www.unaids.org\/sites\/default\/files\/country\/documents\/NGA_narrative_report_2015.pdf<\/ext-link>."},{"key":"ref14","unstructured":"World Bank. Nigeria: Data. 2016. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/data.worldbank.org\/country\/nigeria-cp_wdi\" xlink:type=\"simple\">http:\/\/data.worldbank.org\/country\/nigeria-cp_wdi<\/ext-link>."},{"key":"ref15","unstructured":"HIV and AIDS Estimates 2014: Nigeria. 2015. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/en\/regionscountries\/countries\/nigeria\" xlink:type=\"simple\">http:\/\/www.unaids.org\/en\/regionscountries\/countries\/nigeria<\/ext-link>."},{"key":"ref16","unstructured":"Federal Republic of Nigeria National Agency for the Control of AIDS. Global AIDS response: Country progress report, Nigeria. 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/en\/dataanalysis\/knowyourresponse\/countryprogressreports\/2012countries\/Nigeria2012GARPRReportRevised.pdf\" xlink:type=\"simple\">http:\/\/www.unaids.org\/en\/dataanalysis\/knowyourresponse\/countryprogressreports\/2012countries\/Nigeria2012GARPRReportRevised.pdf<\/ext-link>."},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.4102\/ajlm.v4i1.190","article-title":"Building laboratory capacity to support HIV care in Nigeria: Harvard\/APIN PEPFAR, 2004\u20132012","volume":"4","author":"DJ Hamel","year":"2015","journal-title":"Afr J Lab Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijmedinf.2014.09.006","article-title":"Scale-up of networked HIV treatment in Nigeria: creation of an integrated electronic medical records system","volume":"84","author":"B Chaplin","year":"2015","journal-title":"Int J Med Inform"},{"key":"ref19","unstructured":"Federal Ministry of Health Nigeria. National guidelines for HIV and AIDS treatment and are in adolescents and adults. Abuja, Nigeria. 2007. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/amds\/Nigeria_adult_2007.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/amds\/Nigeria_adult_2007.pdf<\/ext-link>."},{"key":"ref20","unstructured":"Federal Ministry of Health Nigeria. National guidelines for HIV and AIDS treatment and care in adolescents and adults. Abuja, Nigeria. 2010. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/guidelines\/nigeria_art.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/guidelines\/nigeria_art.pdf<\/ext-link>."},{"key":"ref21","unstructured":"World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach, 2003 Revision. Geneva, Switzerland. 2003. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/prev_care\/en\/arvrevision2003en.pdf?ua=1\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/prev_care\/en\/arvrevision2003en.pdf?ua=1<\/ext-link>."},{"key":"ref22","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach\u20142006 rev. Geneva. 2006. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/guidelines\/artadultguidelines.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/guidelines\/artadultguidelines.pdf<\/ext-link>."},{"key":"ref23","unstructured":"World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach\u20142010 rev. Geneva. 2010. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf\" xlink:type=\"simple\">http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599764_eng.pdf<\/ext-link>."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"ofv154","DOI":"10.1093\/ofid\/ofv154","article-title":"Tuberculosis incidence and risk factors among human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy in a large HIV program in Nigeria","volume":"2","author":"CA Chang","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11904-007-0027-4","article-title":"Use of pharmacy refill data as a measure of antiretroviral adherence","volume":"4","author":"R Grossberg","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1186\/1471-2458-14-1035","article-title":"Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings","volume":"14","author":"RZ Sangeda","year":"2014","journal-title":"BMC Public Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/aid.2008.0035","article-title":"Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy","volume":"24","author":"JD Goldman","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00126334-200004010-00016","article-title":"Adherence to triple therapy and viral load response","volume":"23","author":"S Low-Beer","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.qai.0000225015.43266.46","article-title":"Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults","volume":"43","author":"JB Nachega","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(06)69118-6","article-title":"Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda","volume":"368","author":"PJ Weidle","year":"2006","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/QAD.0b013e3283129db0","article-title":"Five-year outcomes of initial patients treated in Botswana&apos;s National Antiretroviral Treatment Program","volume":"22","author":"H Bussmann","year":"2008","journal-title":"AIDS"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAI.0b013e31827a2a7a","article-title":"Risk of virological failure and drug resistance during first and second-line antiretroviral therapy in a 10-year cohort in Senegal: results from the ANRS 1215 cohort","volume":"62","author":"P De Beaudrap","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2010.993","article-title":"Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs","volume":"304","author":"CB Holmes","year":"2010","journal-title":"JAMA"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jpeds.2011.05.038","article-title":"Transition to adult care: systematic assessment of adolescents with chronic illnesses and their medical teams","volume":"159","author":"JS Huang","year":"2011","journal-title":"J Pediatr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/jech-2015-206629","article-title":"CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study","volume":"70","author":"A Grimsrud","year":"2016","journal-title":"J Epidemiol Community Health"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/cid\/civ928","article-title":"Superior effectiveness of zidovudine compared with tenofovir when combined with nevirapine-based antiretroviral therapy in a large Nigerian cohort","volume":"62","author":"KK Scarsi","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa051871","article-title":"Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV","volume":"354","author":"JE Gallant","year":"2006","journal-title":"N Engl J Med"},{"key":"ref38","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and prevention HIV infection: Recommendations for a public health approach. Geneva. 2016. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/208825\/1\/9789241549684_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/208825\/1\/9789241549684_eng.pdf<\/ext-link>."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"ofu055","DOI":"10.1093\/ofid\/ofu055","article-title":"Time-dependent predictors of loss to follow-up in a large HIV treatment cohort in Nigeria","volume":"1","author":"S Meloni","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/cid\/cir729","article-title":"Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings","volume":"53","author":"HE Rawizza","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S2352-3018(15)00002-8","article-title":"Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study","volume":"2","author":"EH Geng","year":"2015","journal-title":"Lancet HIV"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QAI.0b013e31815b833a","article-title":"Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa","volume":"47","author":"RP Dalal","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAI.0b013e3181b843f0","article-title":"Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach","volume":"53","author":"EH Geng","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jama.300.5.506","article-title":"Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa","volume":"300","author":"EH Geng","year":"2008","journal-title":"JAMA"},{"issue":"Suppl 1","key":"ref45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-3156.2010.02507.x","article-title":"Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa","volume":"15","author":"EH Geng","year":"2010","journal-title":"Trop Med Int Health"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0040298","article-title":"Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review","volume":"4","author":"S Rosen","year":"2007","journal-title":"PLoS Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s10461-009-9533-2","article-title":"Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study","volume":"14","author":"DM Tuller","year":"2010","journal-title":"AIDS Behav"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/S2214-109X(13)70149-9","article-title":"Outcomes of the Botswana national HIV\/AIDS treatment programme from 2002 to 2010: a longitudinal analysis","volume":"2","author":"M Farahani","year":"2014","journal-title":"Lancet Glob Health"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cid\/civ556","article-title":"Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: A systematic review and meta-analysis","volume":"61","author":"TS Boender","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0164030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:42:00Z","timestamp":1749667320000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0164030"}},"subtitle":[],"editor":[{"given":"Pierre","family":"Roques","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0164030","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}